SEOUL, South Korea, July 30, 2024 /PRNewswire/ — SwiftMR™, the artificial intelligence (AI) solution for magnetic resonance imaging (MRI) from AIRS Medical, has been approved for use in Canada. Hospitals, radiology centers, and other diagnostic imaging facilities across the country can now leverage this award-winning1 technology, which utilizes deep learning algorithms to reduce scan times and generate clearer images.
SwiftMR™ approved for use
Operating under the laws of the Food and Drugs Act, the Medical Devices Regulations, and supporting guidance documents, Health Canada regulates the sale and importation of medical devices such as MRI scanners. SwiftMR™ has been approved by Health Canada. Since SwiftMR™ is a vendor-neutral application, the MRI scan reconstruction technology can be used in any MRI scanner, regardless of make, model, and field strength.
“Securing Health Canada approval marks a significant milestone for AIRS Medical,” remarked CEO Hyeseong Lee. “Our mission is to revolutionize preventive healthcare through technology innovation, and we’re excited about the transformative potential of SwiftMR™ in Canada.”
A step forward for healthcare in Canada
Through the following benefits, SwiftMR™ helps healthcare providers deliver high quality care:
The SwiftMR™ difference
Now available in over 50 countries and found in more than 400 institutions, SwiftMR™ is helping to increase patient access to diagnostic imaging services worldwide.
To learn more about AIRS Medical and SwiftMR™, visit https://airsmed.com/en.
Ashley Guidace
AIRS Medical
Director of Global Marketing
ashley.guidace@airsmed.com
*For investigational purposes in countries outside of the United States, South Korea, Canada, Brazil, Japan, Taiwan, Malaysia, Saudi Arabia, UAE, Thailand, Vietnam, and Indonesia. FDA 510(k)-cleared to support images with scan time reduction by up to 50% in the United States.
SOURCE AIRS Medical
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…